Wnt5a/β-catenin axis is involved in the downregulation of AT2 lineage by PAI-1
- 1 November 2022
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 323 (5) , L515-L524
Abstract
Failure to regenerate injured alveoli functionally and promptly causes a high incidence of fatality in coronavirus disease 2019 (COVID-19). How elevated plasminogen activator inhibitor-1 (PAI-1) regulates the lineage of alveolar type 2 (AT2) cells for re-alveolarization has not been studied. This study aimed to examine the role of PAI-1-Wnt5a-β catenin cascades in AT2 fate. Dramatic reduction in AT2 yield was observed in Serpine1Tg mice. Elevated PAI-1 level suppressed organoid number, development efficiency, and total surface area in vitro. Anti-PAI-1 neutralizing antibody restored organoid number, proliferation and differentiation of AT2 cells, and β-catenin level in organoids. Both Wnt family member 5A (Wnt5a) and Wnt5a-derived N-butyloxycarbonyl hexapeptide (Box5) altered the lineage of AT2 cells. This study demonstrates that elevated PAI-1 regulates AT2 proliferation and differentiation via the Wnt5a/β catenin cascades. PAI-1 could serve as autocrine signaling for lung injury repair.Keywords
Funding Information
- HHS | NIH | NHLBI | NHLBI Division of Intramural Research (HL134828)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI150550)
- HHS | NIH | National Library of Medicine (LM013460)
This publication has 37 references indexed in Scilit:
- Type 2 alveolar cells are stem cells in adult lungJournal of Clinical Investigation, 2013
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Plasminogen activation inhibitor concentrations in bronchoalveolar lavage fluid distinguishes ventilator-associated pneumonia from colonization in mechanically ventilated pediatric patientsPediatric Critical Care Medicine, 2011
- Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injuryIntensive Care Medicine, 2009
- Transgenic overexpression of a stable Plasminogen Activator Inhibitor-1 variantThrombosis Research, 2009
- From evidence to clinical practice: Effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest*Critical Care Medicine, 2006
- High Concentrations of Plasminogen Activator Inhibitor-1 in Lungs of Preterm Infants With Respiratory Distress SyndromePediatrics, 2006
- Alveolar plasminogen activator inhibitor-1 predicts ARDS in aspiration pneumonitisIntensive Care Medicine, 2005
- Enhanced in Vitro Proliferation of Aortic Endothelial Cells from Plasminogen Activator Inhibitor-1-deficient MiceJournal of Biological Chemistry, 2004
- Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 geneNature, 1990